Ambrisentan

Ambrisentan is a selective endothelin type-A (ETA) receptor antagonist that reduces pulmonary vascular resistance, used in the management of pulmonary arterial hypertension. Simson Pharma's Ambrisentan reference standard and impurities support stability-indicating assay development for this specialised cardiopulmonary therapy.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Ambrisentan Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Ambrisentan
Ambrisentan R isomer
Ambrisentan Vinyloxy Impurity
Ambrisentan Hydroxy Acid Impurity (S-isomer)
Ambrisentan Hydroxy Acid Impurity (R-Isomer)
Ambrisentan Hydroxyester Impurity
Ambrisentan Sulfonyl Pyrimidine Impurity
4,6-Dimethyl-2-hydroxypyrimidine
Ambrisentan Methyl Ester
Ambrisentan Acyl Beta-D-Glucuronide
Ambrisentan N-oxide
4-Hydroxymethyl ambrisentan acyl beta-glucuronide
Ambrisentan Impurity 6
(S)-methyl-2-hydroxy-3-methoxy-3,3-diphenylpropanoate
Ambrisentan Epoxide
Ambrisentan Impurity 1
Ambrisentan Impurity E
Ambrisentan Ethyl Ester
Ambrisentan Methyl Ester Racemate
Ambrisentan Pyrimidine Ester Impurity
Rac O-Demethyl Ambrisentan
Ambrisentan Acyl Glucuronide (Mixture of Diastereomers)

Metabolites

Ambrisentan 4-Hydroxymethyl Analog Racemate
4-hydroxymethyl ambrisentan

Isotope Labelled Compounds

Ambrisentan D3
Ambrisentan-D10
Rac-Ambrisentan-D5